June 7, 2018

Two-Year Data from BAVENCIO (avelumab) in Metastatic Merkel Cell Carcinoma

Paul Nghiem, MD, PhD, discusses his findings at the ASCO 2018 meeting.

Paul Nghiem, MD, PhD, discusses his findings at the ASCO 2018 meeting.

Topics:

ASCO 2018 Skin Cancer

Next post in ASCO 2018

Whether cryosurgery or cryoablation will prove a viable alternative to lumpectomy — the standard of

mFOLFIRINOX After Resection May Lead to Improved Outcomes in Pancreatic Carcinoma